PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor
Source: SeekingAlpha
2025-11-06 06:16:34 ET
...
Read the full article on Seeking Alpha
For further details see:
PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor
PTC Therapeutics Inc.
NASDAQ: PTCT
PTCT Trading
-2.01% G/L:
$65.59 Last:
194,818 Volume:
$67 Open:
PTCT Latest News
March 03, 2026 10:11:53 am
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing
February 19, 2026 04:01:00 pm
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PTCT Stock Data
$5,800,830,036
75,872,448
1.06%
134
N/A
Biotechnology & Life Sciences
Healthcare
US
Warren
